Sanjay Gupta: New non-opioid pain medication ‘a pretty big deal'
Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is 'a pretty big deal.'
'This is a pretty big deal,' Gupta said. 'As you just mentioned, it's been since 1998 that there's been a new pain medication approved. I mean, the FDA typically approves dozens of medications for all sorts of things, but not pain, so patients really haven't had many options.'
The 'The Lead with Jake Tapper' on CNN comments from Gupta follow Journavx (suzetrigine) oral tablets being approved by the U.S Food and Drug Administration (FDA) last week as a first-in-class non-opioid analgesic for the treatment of acute pain in adults.
'Today's approval is an important public health milestone in acute pain management,' said Jacqueline Corrigan-Curay, the FDA's Center for Drug Evaluation and Research acting director, in a previous statement.
'A new non-opioid analgesic therapeutic class for acute pain offers an opportunity to mitigate certain risks associated with using an opioid for pain and provides patients with another treatment option,' she continued.
The approval of the medication is innovating due to it providing another option besides opioids. Americans in the tens of millions are prescribed opioids like oxycodone and fentanyl for pain each year.
'I think what is unique about this, if you think about opioids that you just mentioned, they tend to work primarily on the brain,' Gupta said Tuesday. 'The brain processes all pain, so … that's why they're sedating, they can cause problems with addiction.'
'These pain medications, suzetrigine, Journavx as it's called, works sort of more at the location of the pain, sort of trying to block the signals coming from the source of pain, going to the brain. As a result, you shouldn't get euphoria,' he added.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
FDA commissioner: Measles killing about one in 1,000 victims
(NewsNation) — Health officials in the U.S. are telling all travelers that regardless of where you're flying to, it's important to make sure you're vaccinated against measles. The Centers for Disease Control and Prevention updated its guidance last week. The health agency previously advised travelers of the importance of vaccination for travelers going to countries that have had an outbreak of the disease. Lead, arsenic found in popular rice brands: Study FDA Commissioner Dr. Marty Makary told NewsNation that measles has a mortality rate of about one in 1,000 people, and usually found in people with co-morbid conditions. But he added that vaccination is effective, and that those who've had the disease before needn't worry. 'It's basically natural immunity once you've recovered from measles,' Makary said. The travel notice advises two vaccination doses for all Americans ages 1 and older. An early dose is advised for traveling infants ages 6 months to 11 months. The U.S. has seen more than 1,000 measles cases so far this year. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
19 minutes ago
- Yahoo
FDA commissioner Marty Makary to review safety of abortion drug mifepristone
June 4 (UPI) -- Food and Drug Administration Commissioner Marty Makary said he plans to review the safety of abortion drug mifepristone after a recent study raised concerns about medical side effects. In a letter to Sen. Josh Hawley, R-Mo., Makary revealed the FDA's plan on Monday to review the abortion pill after Hawley alerted the commissioner to the study. "As the Commissioner of Food and Drugs, I am committed to conducting a review of mifepristone and working with the professional career scientists at the agency who review this data," Makary wrote. "As with all drugs, FDA continues to closely monitor the postmarketing safety data on mifepristone for the medical termination of early pregnancy," Makary added. Hawley referred the FDA commissioner to the recent study, from the Ethics and Public Policy Center, which found 11% of women experienced sepsis, infection or hemorrhaging within 45 days of taking the pill. While Hawley said that information is listed as a side effect for mifepristone, the numbers are 22 times greater than the label warns. The study was based on insurance claims for 865,727 mifepristone abortions between 2017 and 2023. "I'm calling on the FDA to reinstate safety regulations on the chemical abortion drug immediately. New data out today show a massive number of severe medical side effects," Hawley said in April. "The time to act is now." Makary told senators during his confirmation hearing in March that he would oversee a review of mifepristone, but did not order it until Hawley alerted him to the EPPC study. The FDA commissioner did express concerns earlier this year about the Biden administration's policy, which allowed women to access abortion drugs without making in-person appointments. Last year, the U.S. Supreme Court rejected a challenge to the FDA's approval of mifepristone, saying the pro-life doctors who brought the case lacked standing. The court said the Alliance for Hippocratic Medicine failed to prove they suffered any harm from the FDA's policies. President Donald Trump, who supported the Supreme Court's decision, was also urged by Hawley to order a mifepristone review over the EPPC's findings.
Yahoo
an hour ago
- Yahoo
Canadian fire smoke threatens air quality in Canada, US as it reaches Europe
Parts of Canada and the US received alerts for hazardous air quality as hundreds of wildfires spread throughout Canada, forcing 26,000 people to evacuate and spewing smoke across the Atlantic in Canada's latest extreme weather event. Canada's wildfires, which have already forced evacuations of more than 26,000 people, continued their stubborn spread Tuesday, with heavy smoke choking millions of Canadians and Americans and reaching as far away as Europe. Alerts were issued for parts of Canada and the neighboring United States warning of hazardous air quality. A water tanker air base was consumed by flames in Saskatchewan province, oil production has been disrupted in Alberta, and officials warned of worse to come with more communities threatened each day. "We have some challenging days ahead of us," Saskatchewan Premier Scott Moe told a news conference, adding that the number of evacuees could rise quickly. Every summer, Canada grapples with forest fires, but an early start to the wildfire season this year and the scale of the blazes -- over two million hectares (494,000 acres) burned -- is worrying. Read moreClimate change made LA wildfires worse, says study The provinces of Saskatchewan and Manitoba have been hardest hit. Both declared wildfire emergencies in recent days. (FRANCE 24 with AFP) Read more on FRANCE 24 EnglishRead also:South Korea firefighters deploy helicopters as country's largest wildfires reigniteWildfire on remote French island threatens wildlife and research station
